• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension.

作者信息

Masugi F, Sakaguchi K, Saeki S, Imaoka M, Ogihara T

机构信息

Department of Geriatric Medicine, Osaka University Medical School, Japan.

出版信息

J Lipid Mediat. 1989 Nov-Dec;1(6):341-8.

PMID:2519902
Abstract

The effects of dietary salt on circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (C16 PAF) in patients with essential hypertension were studied by gas chromatography/mass spectrometry with negative ion chemical ionization. Circulating levels of C16 PAF in patients with essential hypertension (18.1 +/- 5.3 pg/ml, n = 16) were not changed compared with those in normotensive subjects (17.2 +/- 7.2 pg/ml, n = 14). Although changes in circulating levels of C16 PAF were small with changes in dietary salt, net changes in circulating C16 PAF levels significantly and positively correlated with net changes in mean arterial blood pressure (r = 0.47, P less than 0.05). Changes in C16 PAF levels also correlated with changes in creatinine clearance (r = 0.55, P less than 0.05). However, changes in C16 PAF levels did not correlate with changes in plasma sodium concentration, plasma chloride concentration and plasma volume. These results indicate that C16 PAF plays an antihypertensive role and this may be reflected as small changes in circulating levels of C16 PAF.

摘要

相似文献

1
Dietary salt, blood pressure and circulating levels of 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine in patients with essential hypertension.
J Lipid Mediat. 1989 Nov-Dec;1(6):341-8.
2
Studies on the role of platelet-activating factor in blood pressure regulation.
Lipids. 1991 Dec;26(12):1264-8. doi: 10.1007/BF02536544.
3
Radiation-induced increased platelet-activating factor activity in mixed saliva.辐射导致混合唾液中血小板活化因子活性增加。
Lab Invest. 1993 Jan;68(1):118-24.
4
Species-specific variations in the molecular heterogeneity of the platelet-activating factor.血小板活化因子分子异质性的种属特异性差异。
J Immunol. 1987 Mar 1;138(5):1559-63.
5
Platelet-activating factor in human normal tears.
Curr Eye Res. 2005 Oct;30(10):891-6. doi: 10.1080/02713680591001629.
6
[Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].[激素水平及一氧化氮在盐敏感性和盐抵抗性原发性高血压中的作用]
Nefrologia. 2000 Sep-Oct;20(5):415-23.
7
The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.盐摄入量对轻度原发性高血压患者血浆降钙素基因相关肽的影响。
J Hypertens. 1994 Nov;12(11):1249-53.
8
Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
Drugs Exp Clin Res. 1991;17(7):343-9.
9
Cardiopulmonary and intravascular alterations during the sustained infusion of PAF.
J Lipid Mediat. 1991 Sep-Oct;4(2):145-63.
10
Changes in plasma lipids and uric acid with sodium loading and sodium depletion in patients with essential hypertension.原发性高血压患者钠负荷和钠缺失时血浆脂质及尿酸的变化
J Hum Hypertens. 1988 Mar;1(4):293-8.

引用本文的文献

1
PAF. A review of its effects, antagonists and possible future clinical implications (Part II).血小板活化因子。其作用、拮抗剂及未来可能的临床意义综述(第二部分)
Drugs. 1991 Aug;42(2):174-204. doi: 10.2165/00003495-199142020-00002.